Berry Street Capital Management’s Amedisys AMED Stock Holding History

Berry Street Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$5.84M	Buy	+62,500	New	+$5.78M	1.72%	16

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Berry Street Capital Management's AMED Position: Q3 2023 in Review

Berry Street Capital Management opened a new position in Amedisys (AMED) in Q3 2023: 62,500 shares worth $5.84M. The stake represents 1.72% of the portfolio and ranks #16 among its holdings.

287 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

Berry Street Capital Management held 62,500 shares of Amedisys worth $5.84M as of Q3 2023.
Amedisys was a new Berry Street Capital Management position in Q3 2023.
Amedisys made up 1.72% of Berry Street Capital Management's portfolio in Q3 2023, its #16 holding.
287 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Berry Street Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.